Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
CA 2220024 C · Owner: Hellberg, Mark R. · Inventors: Hellberg, Mark R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds useful, as cytoprotective agents of formula (I), wherein z, =(a) and (b); n = 0-12; m = 0-12; X = nothing, NR1, O, or S(O)n'; provided that when X = NR1, O, or S(O)n', then m>0 and n>0; n' = 0-2; R1 = H, C1-C6 alkyl; R = OH or a pharmaceutically, acceptable salt thereof C1-C6 alkoxyl, amino, mono- or dialkylamino where the alkyl has from, 1 to 4 carbon atoms or a, radical of an amino acid, of the formula: -NH- (CH2)n-CH(R2) CO-R3;, R2 = H, C1-C4 alkyl optionally substituted by, hydroxy, SH SCH3, or, (un)substituted phenyl; and, R3 = OH C1-C6 alkoxyl, amino, or mono- or dialkyl amino where the alkyl has from 1 to 4 carbon atoms. The compounds possess dual activity, containing a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 19, 1997 and granted June 25, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 19, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 19, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.